SPY422.11-2.37 -0.56%
DIA340.76-2.65 -0.77%
IXIC14,039.68-33.17 -0.24%

Syndax Pharmaceuticals Q1 Loss Narrows, Revenue Unchanged

05/11/2021 12:12

04:11 PM EDT, 05/11/2021 (MT Newswires) -- Syndax Pharmaceuticals (SNDX) on Tuesday reported a Q1 loss of $0.54 per share, narrower than a loss of $0.56 a year ago. Analysts polled by Capital IQ expected a loss of $0.67.

License fee revenue was unchanged at $379,000. The Street expected $230,000.

Price: 17.09, Change: +1.05, Percent Change: +6.55